93 related articles for article (PubMed ID: 7538349)
21. Expansion of HPCs from cord blood in a novel 3D matrix.
Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
[TBL] [Abstract][Full Text] [Related]
22. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of human CD34+CD38- cord blood stem cells into B cell progenitors in vitro.
Rawlings DJ; Quan S; Hao QL; Thiemann FT; Smogorzewska M; Witte ON; Crooks GM
Exp Hematol; 1997 Jan; 25(1):66-72. PubMed ID: 8989909
[TBL] [Abstract][Full Text] [Related]
24. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
[TBL] [Abstract][Full Text] [Related]
25. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
26. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy.
Ferrero D; Cherasco C; Ortolano B; Giaretta F; Bruno B
Haematologica; 1999 May; 84(5):390-6. PubMed ID: 10329916
[TBL] [Abstract][Full Text] [Related]
27. Proliferation of individual hematopoietic progenitors purified from umbilical cord blood.
Mayani H; Lansdorp PM
Exp Hematol; 1995 Dec; 23(14):1453-62. PubMed ID: 8542931
[TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
Nishi N; Ishikawa R; Inoue H; Nishikawa M; Kakeda M; Yoneya T; Tsumura H; Ohashi H; Yamaguchi Y; Motoki K; Sudo T; Mori KJ
Exp Hematol; 1996 Sep; 24(11):1312-21. PubMed ID: 8862442
[TBL] [Abstract][Full Text] [Related]
30. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
[TBL] [Abstract][Full Text] [Related]
32. Murine stromal cell line HESS-5 maintains reconstituting ability of Ex vivo-generated hematopoietic stem cells from human bone marrow and cytokine-mobilized peripheral blood.
Shimakura Y; Kawada H; Ando K; Sato T; Nakamura Y; Tsuji T; Kato S; Hotta T
Stem Cells; 2000; 18(3):183-9. PubMed ID: 10840071
[TBL] [Abstract][Full Text] [Related]
33. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
34. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
35. Age-related decline in proliferative potential of purified stem cell candidates.
Lansdorp PM; Dragowska W; Thomas TE; Little MT; Mayani H
Blood Cells; 1994; 20(2-3):376-80; discussion 380-1. PubMed ID: 7538342
[TBL] [Abstract][Full Text] [Related]
36. The characteristics of umbilical cord blood (UCB) and UCB transplantation.
Kasai M; Masauzi N
Semin Thromb Hemost; 1998; 24(5):491-5. PubMed ID: 9834019
[TBL] [Abstract][Full Text] [Related]
37. Correlation of c-kit expression and cell cycle regulation by transforming growth factor-beta in CD34+ CD38- human bone marrow cells.
Morita N; Yamamoto M; Tanizawa T
Eur J Haematol; 2003 Nov; 71(5):351-8. PubMed ID: 14667198
[TBL] [Abstract][Full Text] [Related]
38. A functional comparison of CD34 + CD38- cells in cord blood and bone marrow.
Hao QL; Shah AJ; Thiemann FT; Smogorzewska EM; Crooks GM
Blood; 1995 Nov; 86(10):3745-53. PubMed ID: 7579341
[TBL] [Abstract][Full Text] [Related]
39. Characterization of CD34+HLA-DR-CD38+ and CD34+HLA-DR-CD38- progenitor cells from human umbilical cord blood.
Cicuttini FM; Welch K; Boyd AW
Growth Factors; 1994; 10(2):127-34. PubMed ID: 7520715
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic progenitors cells in cord blood.
Thierry D; Hervatin F; Traineau R; Brossard Y; Stark R; Benbunan M; Gluckman E
Bone Marrow Transplant; 1992; 9 Suppl 1():101-4. PubMed ID: 1354516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
